BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 894674)

  • 1. Synthesis of angiotensin II antagonists by incorporating alpha-methylalanine or O-methylthreonine residues in angiotension II analogues.
    Khosla MC; Muñoz-Ramírez H; Hall MM; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Aug; 20(8):1051-5. PubMed ID: 894674
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
    Khosla MC; Hall MM; Munoz-Ramírez H; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrolyte alterations in vascular smooth muscle and hypotensive activity of a new chalcone derivative.
    Sherman GP; Packman EW; Rossi GV
    J Pharm Sci; 1968 May; 57(5):733-7. PubMed ID: 4297948
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemistry and mechanism of new angiotensin UU antagonists: 8 C-phenylclycine analogues of [5-isoleucine] angiotensin].
    Wissmann H; Schoelkens B; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1083-96. PubMed ID: 4376799
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
    Paiva AC; Nouailhetas VL; Paiva TB
    J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of smooth muscle receptors for angiotensin: studies with an antagonist.
    Mimran A; Hinrichs KJ; Hollenberg NK
    Am J Physiol; 1974 Jan; 226(1):185-90. PubMed ID: 4358849
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological data on crinia-angiotensin II.
    Erspamer GF; Nakajima T; Yasuhara T
    J Pharm Pharmacol; 1979 Oct; 31(10):720. PubMed ID: 41055
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of angiotensin II and some analogs in intact strips and in muscle preparations of rabbit aortae.
    Magnan J; Regoli D
    Can J Physiol Pharmacol; 1978 Feb; 56(1):39-47. PubMed ID: 638855
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of drug-receptor theories to angiotensin.
    Rioux F; Park WK; Regoli D
    Can J Physiol Pharmacol; 1973 Sep; 51(9):665-72. PubMed ID: 4356667
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin II. Synthesis and biological activity of 6-(1-methylhistidine) and 6-(3-methylhistidine) analogs.
    Needleman P; Marshall GR; Rivier J
    J Med Chem; 1973 Sep; 16(9):968-70. PubMed ID: 4355510
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial inhibition of prostaglandin-induced contraction of the rat colon by analogues of angiotensin II.
    Sirois P; Gagnon DJ
    J Pharm Pharmacol; 1980 Mar; 32(3):232-3. PubMed ID: 6103950
    [No Abstract]   [Full Text] [Related]  

  • 15. Biologically active derivatives of angiotensin for labeling cellular receptors.
    Galardy RE; Stafford SS; Schaefer ML; Ho H; La Vorgna KA; Jamieson JD
    J Med Chem; 1978 Dec; 21(12):1279-83. PubMed ID: 214560
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of (5-valine,7-N-methylalanine)-angiotensin II, a hypertensive peptide.
    Andreatta RH; Scheraga HA
    J Med Chem; 1971 Jun; 14(6):489-92. PubMed ID: 4327021
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of paired analogs of angiotensin II and angiotensin III on rat smooth muscle.
    Moore GJ; Ko EM
    Pharmacology; 1980; 20(1):36-41. PubMed ID: 7375500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A carboxy-terminus truncated analogue of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists.
    Bovy PR; Trapani AJ; McMahon EG; Palomo M
    J Med Chem; 1989 Mar; 32(3):520-2. PubMed ID: 2918497
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and pharmacological properties of [1-N4-dimethyl-asparagine]-angiotensin II.
    Cordopatis P; Brison J; Dirkx J; Theodoropoulos D
    Experientia; 1979 Jul; 35(7):849-50. PubMed ID: 477828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new short-acting antagonist of angiotensin II.
    Türker RK; Yamamoto M; Bumpus FM
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):162-9. PubMed ID: 4352152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.